Ampio Pharmaceuticals appoints Dan Stokely CFO

Ampio Pharmaceuticals appoints Dan Stokely CFO

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a development stage biopharmaceutical company focused on the discovery and development of a novel therapy aimed at treating common... Read More

Thursday July 11, 2019 0 comments Tags: Englewood, Ampio Pharmaceuticals, Dan Stokely, Michael Macaluso

Ampio Pharmaceuticals offers $12M in stock to public to fund clinical trial

Ampio Pharmaceuticals offers $12M in stock to public to fund clinical trial

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it will offer up to $12 million of its common stock in a public offering. Ampio said it has entered into agreements... Read More

Tuesday June 18, 2019 0 comments Tags: Englewood, Ampio Pharmaceuticals

Ampio updates regulatory status for Ampion drug

Ampio updates regulatory status for Ampion drug

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE MKT: AMPE) announced it met with the FDA on Dec. 12 to discuss final guidance to achieve regulatory approval for its osteoarthritis drug Ampion.... Read More

Friday December 14, 2018 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion

Ampio provides update on Ampion regulatory review

Ampio provides update on Ampion regulatory review

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) reports favorable regulatory and peer-review on the status of Ampion, the companys drug for osteoarthritis of the knee. ... Read More

Tuesday November 27, 2018 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion

Ampio updates Ampion regulatory progress

Ampio updates Ampion regulatory progress

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) is providing an update of the regulatory and clinical path activities required to file a Biologics License Application (BLA) for Ampion... Read More

Monday November 12, 2018 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Mike Macaluso

Ampio Pharmaceuticals announces stock offering to raise $8M

Ampio Pharmaceuticals announces stock offering to raise $8M

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), today announced the pricing of an underwritten public offering of 20 million shares of its common stock and warrants to purchase up to... Read More

Monday August 13, 2018 0 comments Tags: Englewood, Ampio Pharmaceuticals

Ampio: Ampion achieves major decrease in patient osteoarthritis knee pain

Ampio: Ampion achieves major decrease in patient osteoarthritis knee pain

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) reported that the Phase 3 clinical trial of Ampion met its primary endpoint with 71% of Ampion treated patients meeting the... Read More

Friday December 15, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, Michael Macaluso

Ampio seeks to raise $6.75M through stock sale

Ampio seeks to raise $6.75M through stock sale

ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced it has entered into a securities purchase agreement with investors for the registered sale of approximately$6.75... Read More

Tuesday October 17, 2017 0 comments Tags: Englewood, Ampio Pharmaceuticals